Steven H. Kanzer
Director/Board Member at Effective Pharmaceuticals, Inc.
Profile
Steven H.
Kanzer founded Theriva Biologics, Inc. in 2001, where he worked as Director from 2001 to 2014.
Mr. Kanzer also founded Avigen, Inc. and Developmental Therapeutics, Inc., where he worked as Chairman, President & Chief Executive Officer in 2003.
Mr. Kanzer also currently works at Effective Pharmaceuticals, Inc., as Director from 2000, CD4 Biosciences, Inc., as Director from 2000, and Epitope Pharmaceuticals, Inc., as Director.
Mr. Kanzer also formerly worked at Sheffield Pharmaceuticals, Inc., as Chief Executive Officer, Institute for Drug Research, as Chief Executive Officer in 1999, Pipex Therapeutics, Inc., as Chairman & Chief Executive Officer, Soligenix, Inc., as Non-Executive Vice Chairman from 1996 to 2007, Windtree Therapeutics, Inc., as Chairman, Licensing Executives Society, as Co-Chairman, Paramount Capital, Inc., as Senior Managing Director, Solovax, Inc., as Director from 2011 to 2014, Putney Drug Corp., as Director from 2000 to 2014, and PolaRx Biopharmaceuticals, as President.
Mr. Kanzer received his graduate degree in 1988 from New York University and undergraduate degree in 1985 from Baruch College.
Steven H. Kanzer active positions
| Companies | Position | Start |
|---|---|---|
Effective Pharmaceuticals, Inc.
 Effective Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Theriva Biologics, Inc., Effective Pharmaceuticals, Inc. develops and produces pharmaceutical products for auto-immune diseases. The company is based in New York, NY. Effective Pharmaceuticals was acquired by Theriva Biologics, Inc. on January 12, 2007. | Director/Board Member | 17/05/2010 |
CD4 Biosciences, Inc.
 CD4 Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Theriva Biologics, Inc., CD4 Biosciences, Inc. develops and produces pharmaceutical products for the treatment of auto-immune diseases. The company is based in Wilmington, DE. CD4 Biosciences was acquired by Effective Pharmaceuticals, Inc., part of Theriva Biologics, Inc. on December 31, 2004 for $0.0 million. | Director/Board Member | 17/05/2010 |
| Epitope Pharmaceuticals, Inc. | Director/Board Member | 10/04/2011 |
Former positions of Steven H. Kanzer
| Companies | Position | End |
|---|---|---|
| THERIVA BIOLOGICS, INC. | Founder | 25/02/2014 |
Pipex Therapeutics, Inc.
 Pipex Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pipex Therapeutics, Inc. develops drugs for the treatment of neurologic and fibrotic diseases. The firm has three subsidiaries, Effective Pharmaceuticals, Inc., CD4 Biosciences, Inc. and Solovax, Inc. It is located in Ann Arbor, MI. | Chief Executive Officer | 25/02/2014 |
Solovax, Inc.
 Solovax, Inc. Pharmaceuticals: MajorHealth Technology Part of Theriva Biologics, Inc., Solovax, Inc. is a pharmaceutical company that manufactures pharmaceutical goods. The company is based in Wilmington, DE. Solovax was acquired by Pipex Therapeutics, Inc., part of Theriva Biologics, Inc. on July 31, 2005. | Director/Board Member | 25/02/2014 |
| Putney Drug Corp. | Director/Board Member | 25/02/2014 |
| SOLIGENIX, INC. | Director/Board Member | 27/05/2007 |
Training of Steven H. Kanzer
| New York University | Graduate Degree |
| Baruch College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| THERIVA BIOLOGICS, INC. | Health Technology |
| Private companies | 13 |
|---|---|
| Sheffield Pharmaceuticals, Inc. | Health Technology |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Health Technology |
| Paramount Capital, Inc. | |
Effective Pharmaceuticals, Inc.
Effective Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Theriva Biologics, Inc., Effective Pharmaceuticals, Inc. develops and produces pharmaceutical products for auto-immune diseases. The company is based in New York, NY. Effective Pharmaceuticals was acquired by Theriva Biologics, Inc. on January 12, 2007. | Health Technology |
Institute for Drug Research
 Institute for Drug Research Miscellaneous Commercial ServicesCommercial Services Part of Institute for Drug Research Private Group, Institute for Drug Research provides drug testing and research services. The company is based in Budapest, Hungary. Institute for Drug Research was acquired by Institute for Drug Research Private Group on April 09, 1998. | Commercial Services |
PolaRx Biopharmaceuticals
 PolaRx Biopharmaceuticals Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, PolaRx Biopharmaceuticals is a company that manufactures TriOxide drugs for the treatment of leukemia and other cancers. The company is based in New York, NY. The company was founded by Fred H. Mermelstein, Peter Morgan Kash, Raymond P. Warrell. PolaRx Biopharmaceuticals was acquired by CTI BioPharma Corp., part of Swedish Orphan Biovitrum AB from June 27, 2023 on January 13, 2000 for $17.50 million. | Commercial Services |
Pipex Therapeutics, Inc.
Pipex Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pipex Therapeutics, Inc. develops drugs for the treatment of neurologic and fibrotic diseases. The firm has three subsidiaries, Effective Pharmaceuticals, Inc., CD4 Biosciences, Inc. and Solovax, Inc. It is located in Ann Arbor, MI. | Health Technology |
| Licensing Executives Society | |
CD4 Biosciences, Inc.
CD4 Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Theriva Biologics, Inc., CD4 Biosciences, Inc. develops and produces pharmaceutical products for the treatment of auto-immune diseases. The company is based in Wilmington, DE. CD4 Biosciences was acquired by Effective Pharmaceuticals, Inc., part of Theriva Biologics, Inc. on December 31, 2004 for $0.0 million. | Health Technology |
Solovax, Inc.
Solovax, Inc. Pharmaceuticals: MajorHealth Technology Part of Theriva Biologics, Inc., Solovax, Inc. is a pharmaceutical company that manufactures pharmaceutical goods. The company is based in Wilmington, DE. Solovax was acquired by Pipex Therapeutics, Inc., part of Theriva Biologics, Inc. on July 31, 2005. | Health Technology |
| Developmental Therapeutics, Inc. | |
| Putney Drug Corp. | |
| Epitope Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Steven H. Kanzer
